Remission in chronic rhinosinusitis with nasal polyps (CRSwNP)

Indexed in

License and use

Citations

Altmetrics

Analysis of institutional authors

Mullol, JAuthor

Publications

Letters

Publicated to:Rhinology. 63 (2): 240-241 - 2025-01-01 63(2), DOI: 10.4193/Rhin24.457

Authors: Hellings, P W; Hellings, P W; De Corso, E; De Corso, E; Backer, V; Backer, V; Bernal-Sprekelsen, M; Bernal-Sprekelsen, M; Chan, Y; Chan, Y; Conti, D M; Conti, D M; Cornet, M E; Cornet, M E; Fokkens, W J; Fokkens, W J; Gevaert, P; Gevaert, P; Han, J; Han, J; Hopkins, C; Hopkins, C; Landis, B N; Landis, B N; Lau, S; Lau, S; Lee, S; Lee, S; Lund, V J; Lund, V J; Mullol, J; Mullol, J; Peters, A; Peters, A; Schneider, S; Schneider, S; Senior, B; Senior, B

Affiliations

Alrijne Hosp, Dept Otorhinolaryngol, Leiderdorp, Netherlands - Author

Charite Univ Med Berlin, Dept Pediat Resp Med Immunol & Crit Care Med, Berlin, Germany - Author

CIBERES, Barcelona, Catalonia, Spain - Author

Eastern Virginia Med Sch, Dept Otolaryngol & Head & Neck Surg, Norfolk, VA USA - Author

Fdn Policlin Univ A Gemelli IRCCS, UOC Otorinolaringoiatria, Rome, Italy - Author

FRCB IDIBAPS, Barcelona, Catalonia, Spain - Author

Guys & St Thomas Hosp NHS Fdn Trust, Dept Rhinol, Skull Base Surg, London, England - Author

Hosp Clin Barcelona, ENT Dept, Smell Clin, Rhinol Unit, Barcelona, Catalonia, Spain - Author

Johns Hopkins Sch Med, Dept Otolaryngol Head & Neck Surg, Div Rhinol & Skull Base Surg, Baltimore, MD USA - Author

Katholieke Univ Leuven, Dept Microbiol & Immunol, Allergy & Clin Immunol Res Unit, Leuven, Belgium - Author

Med Univ Vienna, Dept Otorhinolaryngol, Vienna, Austria - Author

Northwestern Univ, Feinberg Sch Med, Dept Med, Div Allergy & Immunol, Chicago, IL USA - Author

Royal Natl Ear Nose & Eastman Dent Hosp, London, England - Author

Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Otorhinolaryngol & Head Neck Surg, Locat AMC, Amsterdam, Netherlands - Author

Univ Autonoma Madrid, Escuela Doctorado UAM, Ctr Estudios Posgrad, Calle Francisco Tomas & Valiente 2,Ciudad Univ Can, Madrid 28049, Spain - Author

Univ Barcelona, Barcelona, Catalonia, Spain - Author

Univ Barcelona, Clin Barcelona, Barcelona, Spain - Author

Univ Coll London Hosp, Royal Natl Ear Nose & Throat & Eastman Dent Hosp, London, England - Author

Univ Copenhagen, Dept Otorhinolaryngol Head & Neck Surg & Audiol, Rigshosp, Copenhagen, Denmark - Author

Univ Ghent, Dept Head & Skin, Upper Airways Res Lab, Ghent, Belgium - Author

Univ Hosp Geneva, Dept Otorhinolaryngol Head & Neck Surg, Rhinol Olfactol Unit, Geneva, Switzerland - Author

Univ Hosp Leuven, Clin Dept Otorhinolaryngol Head & Neck Surg, Leuven, Belgium - Author

Univ North Carolina, Dept Otolaryngol Head & Neck Surg, Chapel Hill, NC USA - Author

Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada - Author

Abstract

Remission has recently been proposed as the new goal of care in CRSwNP or Nasal Polyp Syndrome by the European Forum for Research and Education in Allergy and Airway Diseases / European Position Paper on Rhinosinusitis and Nasal Polyps (EUFOREA/EPOS) (1,2) as well as by global leaders in Rhinology (3). In CRSwNP, remission is defined as a prolonged state of control, without bothersome symptoms reported by the patient for at least 12 months, without the need for either oral corticosteroids or endoscopic sinus surgery (ESS), and without endoscopic signs of active disease (1). This new goal of care is to be encouraged by the ENT community and CRSwNP patients as persistent symptoms unalleviated by historical approaches (4,5) can be reduced by new therapies including biologics. The goal of therapy for CRSwNP has long been to achieve control, with Visual Analogue Scale (VAS) and Sino-Nasal Outcome Test (SNOT-22) scores guiding physicians towards a step-up treatment aiming for control (6,7).

Keywords

Ciências biológicas iGeneral medicineMedicina iMedicina iiMedicina iiiMedicine (miscellaneous)OdontologíaOtorhinolaryngologySaúde coletiva

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Rhinology due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2025, it was in position 3/66, thus managing to position itself as a Q1 (Primer Cuartil), in the category Otorhinolaryngology. Notably, the journal is positioned above the 90th percentile.

Leadership analysis of institutional authors

This work has been carried out with international collaboration, specifically with researchers from: Austria; Belgium; Canada; Denmark; Germany; Italy; Netherlands; Switzerland; United Kingdom; United States of America.

Indexed in

License and use

Citations

Altmetrics

Analysis of institutional authors

Share